BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Med’s Industry

AIRS Medical Partners with ParagonCare to Boost SwiftMR™ Sales in Australia and New Zealand

AIRS Medical Inc., a leading provider of AI-powered healthcare solutions, has announced a strategic partnership agreement with ParagonCare Limited&nbs...

February 19, 2024 | News

Synbio Tech's Probiotic TWK10 Earns Taiwan FDA Approval for Anti-fatigue Health Claim

Synbio Tech is thrilled to announce that its groundbreaking probiotic strain, Lactiplantibacillus plantarum TWK10, has been awarded a prestigious...

February 19, 2024 | News

Japan Becomes First in the World to Approve Dupixent® for Chronic Spontaneous Urticaria (CSU)

Approval based primarily on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth appr...

February 17, 2024 | News

STARmed Expedites Global Rollout of EUSRA and ELRA Products in Collaboration with Olympus

Previously distributed by Taewoong Medical Co., Ltd., a Korean gastrointestinal medical device manufacturer, EUSRA and ELRA products will n...

February 16, 2024 | News

FDA Prioritizes Review of Bristol Myers Squibb's Augtyro™ for NTRK-Positive Solid Tumors

Bristol Myers Squibb (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for A...

February 15, 2024 | News

BioAge Secures $170 Million in Series D Funding to Propel Obesity and Metabolic Disease Drug Development

BioAge Labs (“BioAge”), a pioneering biotechnology firm dedicated to advancing novel treatments for obesity and metabolic diseases by e...

February 14, 2024 | News

William Lin Discusses QIAGEN's Role in Transforming Healthcare in Asia-Pacific with Innovative Molecular Diagnostics

In a significant stride towards enhancing healthcare diagnostics in the Asia-Pacific region, QIAGEN has recently garnered attention with the approval of it...

February 13, 2024 | Interaction

Otsuka's AVP-786 Falls Short in Phase 3 Trial for Alzheimer's Agitation

Otsuka Pharmaceutical Development & Commercialization, Inc., (OPDC) and its parent company Otsuka Pharmaceutical, Co. Ltd. (Otsuka) have released the t...

February 13, 2024 | News

Gilead Sciences Bolsters Liver Portfolio Through Acquisition of CymaBay Therapeutics

Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced today a definitive agreement whereby Gilead will acquire CymaBay for $32.50 ...

February 13, 2024 | News

Cytiva and LevitasBio unite to revolutionize single-cell workflow, fast-tracking therapeutic development

Technologies work together to simplify single-cell workflows, saving time for academic researchers. Combined VIA Extractor and LeviCell system a...

February 12, 2024 | News

CooperSurgical® and Fulgent Genetics Introduce Advanced Genetic Testing for Cord Blood Registry® Families

CooperSurgical®, a global leader in fertility and women's health, and Fulgent Genetics, Inc. (NASDAQ: FLGT), a technology-...

February 12, 2024 | News

Aurora Cannabis Expands Global Footprint with Acquisition of MedReleaf Australia

MedReleaf Australia, holding the coveted #2 spot in the rapidly growing Australian medical cannabis market, was acquired by Aurora in a transaction...

February 09, 2024 | News

MGI Partners with Dante Genomics to Expand Presence in the Middle East

Roy Tan, General Manager of MGI Asia Pacific, expressed his enthusiasm during the announcement, "Partnering with Dante Labs underscores our unwavering dedi...

February 08, 2024 | News

Bruker Corporation Acquires Nanophoton Expanding Raman Microscopy Portfolio and Global Reach

Bruker Corporation announced the acquisition of Nanophoton Corporation, a pioneer focused on advanced research Raman microscopy systems. Headquar...

February 08, 2024 | News

Stay Connected